Female contraceptive market set to be worth $8.7bn by 2027
China | News | 0 Comment | 11 Feb, 2019
Contraceptive market sales were estimated to be $6.3bn across the 8MM (US, France, Germany, Italy, Spain, UK, Japan...Read more
Lunar New Year focuses on traditional chinese medicine for cancer treatment
China | Opinion | 0 Comment | 09 Feb, 2019
The Lunar New Year welcomes a focus on the wellbeing of the entire body leading to renewed discussions about the benefit...Read more
CStone, IMPACT Therapeutics’ anti-tumor therapy gets IND filing acceptance
China | News | 0 Comment | 08 Feb, 2019
CStone Pharmaceutical and IMPACT Therapeutics, Inc. have jointly announced that an Investigational New Drug (IND) filing...Read more
Invitrocue signs technology development agreement with SIBCB
China | News | 0 Comment | 08 Feb, 2019
Invitrocue, a leading healthcare bio-analytic solutions provider, has announced the signing of a new technology developm...Read more
Glenmark Pharma signs an agreement with Grandpharma
China | News | 0 Comment | 07 Feb, 2019
Glenmark Pharmaceuticals Ltd. (Glenmark) has announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered i...Read more
EdiGene raises $10M in Series pre-B
China | News | 0 Comment | 06 Feb, 2019
EdiGene Inc., headquartered in Beijing, with operational subsidiaries in Guangzhou, China and Cambridge, USA and which d...Read more
Reaction Biology Corporation buys ProQinase GmbH
China | News | 1 Comment | 05 Feb, 2019
Reaction Biology Corporation ("RBC") and ChinaEquity Group ("CEG") have announced the conclusion of a stock exchange tra...Read more
Accuray, CIRC to sell Radiation Oncology Systems in China
China | News | 0 Comment | 05 Feb, 2019
Accuray Asia Limited, a subsidiary of Accuray Incorporated, and CNNC High Energy Equipment (Tianjin) Co., Ltd, a subsidi...Read more
CARsgen Therapeutics receives IND clearance for GPC3-CAR-T Cells from NMPA
China | News | 0 Comment | 04 Feb, 2019
CARsgen Therapeutics, a clinical-stage company committed to developing Chimeric Antigen Receptor T cell therapies for ca...Read more
I-Mab, BCT to work on Arginine Depletion Therapy and Biomarker Study
China | News | 0 Comment | 04 Feb, 2019
I-Mab Biopharma (I-Mab), a China-based clinical stage biopharmaceutical company exclusively focused on the developm...Read more
GeneQuantum Healthcare, MITRO Biotech to develop Radionuclide Conjugates
China | News | 0 Comment | 04 Feb, 2019
GeneQuantum Healthcare of Suzhou and MITRO Biotech of Nanjing recently signed the "Strategic Cooperation Agreement ...Read more
I-Mab gets USFDA IND approval for its proprietary TJC4
China | News | 0 Comment | 29 Jan, 2019
I-Mab Biopharma (I-Mab), a China-based clinical-stage biopharmaceutical company exclusively focused on the developm...Read more
Ping An Good Doctor develops new offline service scenario
China | News | 0 Comment | 29 Jan, 2019
China's leading one-stop healthcare ecosystem platform Ping An Health Medical Technology Company Limited has announced t...Read more
BioDuro partners with Advent International
China | News | 0 Comment | 28 Jan, 2019
BioDuro, a leading global life sciences contract research and development organization, and Advent International, o...Read more
Amgen receives NMPA approval for Repatha in China
China | News | 0 Comment | 28 Jan, 2019
Biotech Company, Amgen has announced the National Medical Products Administration (NMPA) approval of a new ind...Read more
Pfizer to introduce innovative drugs & therapy for breast cancer in China
China | News | 0 Comment | 23 Jan, 2019
Led by the Shanghai Branch of PICC Health Insurance and the Shanghai MediTrust Health as well as supported by Pfiz...Read more
Merck, Tencent collaborate for intelligent digital healthcare services
China | News | 0 Comment | 23 Jan, 2019
Merck, a leading science and technology company, signed a strategic collaboration agreement with Tencent, a leading prov...Read more
I-Mab Biopharma gets USFDA IND nod for antibody TJD5
China | News | 0 Comment | 23 Jan, 2019
China-based clinical stage biopharmaceutical company, I-Mab Biopharma, exclusively focused on the development of innovat...Read more